In this article we assess variability in cell proliferation dynamics observed for CD4+ and CD8+ T cells collected from two healthy donors. We review a recently developed class of models that incorporates the so-called "cyton model" for cell numbers into a conservation-based PDE model for cell population dynamics and describe a statistical model that relates CFSE-based ow cytometry data to such models. A parameter estimation scheme is summarized and then applied to a large body of data to assess experimental variability (variation in parameter estimates as identical experiments are replicated) and biological variability (di erences in parameter estimates obtained for di erent donors and cell types) in the context of these models. Variability in the data obtained from replicated experiments is also discussed. The results of this study indicate that many of the cyton model parameters for describing cell proliferation can be reliably estimated using our approach; however, they also show that substantial changes to our mathematical model and/or experimental procedures may be required to ensure identi ability of the remaining cell proliferation parameters.
Introduction
The adaptive immune response is a major component of the human immune system's defense against invading pathogens. The adaptive immune system consists of B and T lymphocytes, which recognize invaders by speci c cell surface receptors and exert their responses by soluble and cellular e ector mechanisms. As the success of this system depends on the lymphocytes' capacity to proliferate in response to an infection, the ability to accurately predict this behavior in the presence of speci c environmental stimuli has important implications for human health research in areas such as the treatment and prevention of infectious disease and immunosuppression for organ and tissue transplants. Such predictions can be made through the use of mathematical models.
Over the last half-century, many mathematical models have been proposed that attempt to describe the dynamics of a proliferating population of cells, but until fairly recently it has been a challenge to validate such models. The discovery of the intracellular dye carboxy uorescein succinimidyl ester (CFSE) was a major milestone in overcoming this obstacle. CFSE was originally developed as a tool for labeling lymphocytes so that their movements within animal subjects could be tracked over many months [23] , but subsequently researchers determined that the dye could also be used to monitor lymphocyte proliferation [17] . Also, through the use of uorescently labeled antibodies speci c to various lymphocyte surface markers, it is now possible to follow the proliferative behavior of speci c types of lymphocytes [16] .
In this study, we consider a mathematical model that incorporates the "cyton model" for cell numbers into a partial di erential equation model for cell proliferation dynamics that is based upon the conservation of CFSE mass within a population of proliferating cells. Utilizing a generalized least squares parameter estimation scheme, we t this model to CFSE-based ow cytometry data obtained for CD4+ and CD8+ T cells collected from two healthy donors. Measurements were made in triplicate on each of ve days, making it possible to construct a considerable number of ve-day data sets for each donor and cell type. In theory, each such data set should be very similar, so one might expect that a set of parameters for describing cell proliferation dynamics observed in one of the data sets should be essentially equivalent to those describing observations made using another of the data sets. By applying our parameter estimation scheme to each veday data set, we are able to assess experimental variability in the estimates of the parameters characterizing a speci c cyton-based mathematical model. Also, by collecting data from two di erent human donors and considering two speci c cell types, we are able to make some observations concerning biological variability in the cell proliferation parameters.
Data collection procedure
As discussed above, the goal of this study is to assess the experimental and biological variability in parameter estimates produced using CFSE-based ow cytometry data and cyton-based mathematical models. To obtain such data, we collected blood samples from two human donors and isolated peripheral blood mononuclear cells (PBMCs) from these samples. The PBMCs (hereafter referred to as just "cells") were then passed through a strainer to remove clumps of cells and stained with CFSE according to the standard protocol [16] . Forty-ve minutes after CFSE staining, the cells were stimulated to divide by exposing them to phytohaemagglutinin (PHA), a non-speci c T cell mitogen. Then, approximately one million cells were placed into each of several "wells", which are typical containers for cell culture experiments. Each well contained approximately 1 mL of RPMI-1640/10% fetal calf serum (FCS), which is a typical nutrient medium for such experiments. For each one of the donors, three wells were "seeded" in this way for each of ve measurement times in order to allow for measurements to be obtained in triplicate at each time point; thus, fteen wells were seeded per donor. Since two donors were considered, a total of thirty wells were seeded at the beginning of the experiment.
Here we note that, as cells proliferate, CFSE in a dividing mother cell is distributed to two daughter cells. The CFSE bound to the proteins inside cells also naturally degrades over time. Thus, there are two mechanisms by which the mass of CFSE per cell can decline: cell division and CFSE decay. Such a decline in CFSE per cell can be quanti ed by collecting cells from the wells at various points in time and passing them through a ow cytometer. So, at each of ve time points corresponding to approximately 1, 2, 3, 4, and 5 days after PHA stimulation, we transferred the contents of one of the wells to a sample tube that contained a known number of "beads". (The number of beads in each sample tube is xed and is reported by the manufacturer of the tubes.) The actual times for data collection coincided with 23.5, 46.0, 67.5, 94.5, and 117.5 hours after stimulation with PHA. In order to minimize disruption of proliferating cell populations, the contents of any given well were harvested only once; however, we remark that beginning on Day 3 (after the Day 3 measurement was made) one third of the nutrient medium in each unused well was exchanged with fresh medium every 24 hours and that this exchange of medium could have a ected the cell cultures in the wells that were harvested after Day 3. The cells were then stained with uorochrome-labeled antibodies (anti-CD3, anti-CD4, and anti-CD8) as well as the viability dye known as ViViD, which allows for the identi cation of dead cells that have not yet disintegrated. A sample consisting of a fraction (about 10 to 50%) of the contents of the sample tube was then passed through a ow cytometer. During this process, the ow cytometer measured the uorescence intensity (FI) at various wavelengths of each cell in the sample and counted the number of beads in the sample. Because we processed only a fraction of the contents of each tube, the "actual" cell counts for any given range of FI were obtained by scaling the observed counts upward by the ratio of known number of beads in the tube to counted beads for the sample. As mentioned above, this process was repeated using cells from three di erent wells (per donor) at each measurement time.
Because the FI emitted at wavelengths in the range 515 to 545 nm varies directly with the mass of CFSE within a cell [16, 23] , this FI is a useful surrogate for CFSE mass. Also, because CFSE is allocated evenly (by assumption) to two daughter cells upon cell division, FI histograms associated with a population of cells acquire more "peaks" as the cells divide asynchronously. In Figures 1 through 8 , we present summary histograms for the data collected in our study. Each of these gures illustrates the preceding point. As described in the preceding paragraph, the FI emitted in the "CFSE range" by a given cell may be taken to be synonymous with the mass of CFSE contained in that cell. Therefore, CFSE data can be used to validate a mathematical model describing cell population dynamics that is based upon mass conservation principles. Such a model is described in detail in Section 3. Furthermore, when cells have been labeled with other markers (as is the case for the experiments in this study), information about FI at other wavelengths can be used to distinguish between di erent types of cells (e.g., CD4+ versus CD8+ T cells, or living versus dead cells) [16] .
In order to ascertain variability in parameters and measured data, we require a considerable number of data sets. To this end, we use various combinations of the triplicate samples collected on Days 1 through 5 to form a large number of time series data sets. Since three samples were collected on each of ve days, there should be 3 5 = 243 possible ways to form a ve-day "longitudinal" data set for each donor. However, data for one of the samples corresponding to Donor 1 and Day 4 was not available due to an instrument problem; therefore, there are in fact only 3 4 × 2 = 162 possible ways to form a ve-day data set for Donor 1.
It should explicitly noted that data sets formed in this way do not represent truly longitudinal data because measurements corresponding to each time point were made using distinct cell cultures (wells). In this type of in vitro experiment (see, for example, [16] , [14] , [18] , and [4] ) it is tacitly assumed that the populations of cells in each well are identical (up until the moment cells are harvested from a particular well) in that they include the same numbers of total cells in the same proportions (according to cell type). This assumption allows one to interpret time series data sets formed as described above as having come from longitudinal observations. In reality, however, there can be considerable variation in the cell cultures in the various wells due to experimental error in the initial seeding of the wells. This issue will be discussed further in Section 5.
Mathematical model
Here, we summarize a class of models originally proposed in [22] and further developed in [7] and [4] . We then identify the speci c model to be considered for the purposes of our variability study.
. Basic label-structured model for cell densities
Let ( , ) be a structured density (in cells per unit FI), where is a whole number representing a speci c "generation" of cells (or number of divisions completed), denotes the time elapsed (in hr) since some arbitrary starting time, and denotes FI induced by CFSE. Also, let { ( )}, { ( )}, and ( ) denote exponential division rates, exponential death rates, and the CFSE exponential decay rate, respectively (all in hr −1 ). Then the dynamics of a population of cells are described by
where ≥ 0 and the "recruitment" terms are given by
for ≥ 1. The initial conditions are given by
where 0 indicates the time of the rst observation and Φ( ) is the structured density for cells in the initial (undivided) population. A derivation of this model based on mass conservation principles can be found in [22, Chapter 3] . We remark here that 0 typically coincides with the time at which the cells were stimulated to divide, but for the purposes of our experiment the rst observation actually occurred approximately 24 hours after stimulation. We also mention that the form of the recruitment terms (3.2) assumes an even partitioning of the CFSE in a mother cell between two daughter cells during cytokinesis; i.e., we assume that each daughter cell receives exactly one half of the CFSE that was present in the mother cell. Long-standing results indicate that the partitioning of cytoplasm to two daughter cells during mitosis is not even [21] , and a recent review [10] suggests that incorporating the assumption of asymmetric cell division into mathematical models for cell proliferation will "improve assessment of T cell performance parameters from CFSE-based proliferation assays." Nevertheless, we follow the convention of earlier work [4, 12, 16, 18, 19, 22] in making the simplifying assumption that CFSE is evenly distributed during cell division. As proposed in [19] , the solutions to the system of partial di erential equations (PDEs) given in (3.1) can be factored as
where ( ) indicates the number of cells having completed divisions at time and̄ ( , ) describes the distribution of CFSE within that generation of cells at time ; that is,̄ ( , ) is a probability density function (pdf) in the variable , so that for any xed ,̄ ( , ) ≥ 0 for all and
The variables satisfy the system of ordinary di erential equations (ODEs) given by 4) and have initial conditions given by and the initial condition̄
for ≥ 0. It is worth noting that cells will only divide a nite number of times in the time frame of at typical in vitro cell culturing experiment. Therefore, we typically compute solutions to (3.4) and (3.6) only for ∈ {0, 1, . . . , max }, where max is the largest number of divisions we expect a cell from the initial population to undergo during the period of observation. For a ve-day experiment such as that presented in Section 2, it is rare for cells to undergo more than twelve divisions. In order to capture the behavior of all but a negligible number of cells, we use the conservative value of max = 16 for our purposes in this variability study.
. Autofluorescence
Thus far, we have described a model that accounts only for FI induced by CFSE, but as noted in [22] , the experimentally measured FI of a cell is actually the sum of CFSE-induced FI and the cell's natural "autouorescence". Therefore, following the work of [12] , we let̃ ( ,̃ ) be a structured density (in cells per unit FI), where again denotes a speci c generation of cells, denotes time elapsed (in hr), and̃ denotes measured FI. Here,̃ = + , where and represent the FI due to CFSE and auto uorescence, respectively.
If we assume solutions ( , ) to (3.1) and (3.3) have already been computed and that is a realization of a random variable with pdf ( ; ), then the densities̃ ( ,̃ ) can be computed using the convolution integral [12, 19] 
Under certain assumptions, this convolution integral can be computed quickly and e ciently as demonstrated in [12] .
. Cyton model for cell numbers
We now turn our attention to the cyton model [13, 14] , which is an alternative to (3.4) that arises from two simple assumptions. The rst, which is self-evident, is that any given cell must eventually either divide or die. The second, which is based upon experimental evidence, is that the processes of cell division and death operate independently of one another [14] . Thus, we can assume that the destiny of any particular cell is governed by two xed numbers: a "time until division" and a "time until death". In particular, the actual fate of the cell (division or death) can be determined by observing which of these two numbers is smaller.
For individual cells within a population of cells sharing similar characteristics (e.g., cells of the same type having undergone the same number of divisions), it is reasonable to assume that the "time until division" and "time until death" are realizations of independent random variables. These random variables are described by probability distributions, and so the cyton model requires parameters that can be used to uniquely determine the probability distributions for times until division and death of cells in a given population (e.g., CD4+ T cells having undergone one division). The authors of [14] chose the term "cyton" to denote the "combination of independent cellular machines governing times to divide and die" and represented a cyton mathematically using a pair of probability density functions. For example, if and are the pdfs for time until division and time until death, respectively, of cells in generation , then the cyton for generation can be denoted ( , ). One additional consideration is that, in reality, not all cells in a given population will divide if they avoid death (at least not within the time frame of a typical in vitro cell culturing experiment) [14] . Therefore, the cyton model includes the notion of "progressor fraction": for a given generation of cells, only a certain proportion have the potential to "progress" to the next generation via cell division. Let denote the progressor fraction for generation ; that is, represents the proportion of cells in generation that would (eventually) divide in the absence of any possibility of cell death. Then, de ne the random variable div to be the time required for a cell in generation (with the potential to progress) to complete its next division (measured in hours since the completion of the th division, or in the case of div 0 , hours since 0 ). Similarly, de ne the random variable die to be the time required for a cell in generation to die.
Finally, let ( ) and ( ) be pdfs for div and die , respectively. If we de ne ( ) as before, the cyton model is then given by
where div ( ) and die ( ) are rates (in cells/hr) at which cells in generation divide and die, respectively. These rates are de ned as
and
There is considerable experimental evidence [8, 13, 14] that supports the cyton model, and it has an advantage over models such as (3.4) in that it directly connects cell population numbers to probability distributions describing times at which cells in a given generation will divide or die. Identifying these distributions for populations of lymphocytes exposed to speci c environmental stimuli allows for a detailed quantitative description of the adaptive immune response.
. Label-structured cyton model for cell densities
As in [4] , we incorporate the cyton model for cell numbers into the division-and label-structured model framework described previously by replacing the sink and source terms in the right-hand sides of (3.1) with terms involving the cyton-based rates to obtain
(3.12) Solutions of this system are then given by ( , ) = ( )̄ ( , ), where the variables ( ) satisfy the cyton model equations (3.9) and initial conditions (3.5) and each̄ ( , ) satis es (3.6) and (3.7) as before. Like (3.1), the model given by (3.12) may be properly described as a division-and label-structured population model, as it makes use of structure variables for division number (or generation) and CFSE label content (which is proportional to CFSE-wavelength FI) . Also, as described in [12, 19] and summarized in [4] , the factorable form of the solutions { ( , )} and the technique for converting these to corresponding solutions {̃ ( ,̃ )} via convolution integrals (cf. (3.8)) makes it possible to obtain numerical solutions very quickly when the model parameters are given [4, 12] . This model has been shown to yield a reasonably good t to summary histogram data such as that presented in Figures 1 through 8 , provided that the model parameters are chosen "optimally" [4] . More will be said about optimal parameter estimation in Section 4.
Finally, we remark that (3.12) actually describes an entire class of models. In order to specify a particular model for further investigation, we must decide on forms for the distribution of the auto uorescence , the (exponential) label decay rate ( ), the cytons {( ( ), ( ))}, and the progressor fractions { }.
. Parameterization for a speci c mathematical model
Here, we list the assumptions for the speci c cyton-based mathematical model we consider and describe the parameters that we use to designate this model. All of the parameters for our speci c mathematical model are provided in Table 1 .
First, we assume that the random variable is time-independent and has a lognormal distribution with mean and variance denoted E[ ] and Var[ ], respectively. Although experiments indicate that the distribution of auto uorescence does, in fact, vary with time, ignoring this time-dependence greatly reduces the number of parameters required to designate the model and still allows for a reasonable t to summary histogram data [4] . We therefore have two parameters that completely describe the distribution of autouorescence:
1/2 , which are listed as parameters (1) and (2), respectively, in progressor fraction for cells in generation = 0 mean of discrete normal distribution (used to compute for ≥ 1)
standard deviation of discrete normal distribution (used to compute for ≥ 1) Table 1 . Parameters for speci c mathematical model.
Next, we assume that the rate of decay in CFSE-induced FI is given by ( ) = , where > 0 is some constant. This follows the convention of [4] , in which the authors assume that an exponential decay model is su cient to describe decay of CFSE in experiments for which the rst data collection time occurs after approximately 24 hours. We note that the decay of intracellular CFSE has been observed to occur very rapidly during the rst 24 hours after initial labeling and much slower thereafter [6, 22] and that this observation can be fully supported with molecular-level modeling [1] . Thus, when data are collected in the rst 24 hours, it is more accurate to describe the rate of loss of uorescence intensity with a time-varying rate, as in a Gompertz decay model. For our situation, however, we require only one parameter to completely describe the decay of CFSE: , which is listed as parameter (3) in the aforementioned table.
We shall assume that each div has a lognormal distribution with mean and variance denoted E[ div ]
and Var[ div ], respectively. We further assume that, for ≥ 1, all div are independent and identically distri-
. Such assumptions are consistent with earlier work using the cyton model [4, 13, 14] . We therefore have four parameters that completely describe
for ≥ 1, and
These are listed as parameters (4) [4, 13, 14] . We further assume that there is no death for undivided cells (i.e., those cells in generation = 0). In reality, there tends to be a large die-o of cells following stimulation with PHA [7] , but we reiterate that for this report the rst data were collected approximately 24 hours post-stimulation. As a result, the initial conditions for our mathematical model only re ect those cells that have not died in the rst 24 hours after stimulation. Therefore, as in [4] , we work under the assumption that the cells in our "initial population" (consisting of those undivided cells that are still alive 24 hours after stimulation) that do not go on to divide experience essentially no death for the duration of the experiment. Hence, we have two parameters that completely describe
1/2 for ≥ 1, which are listed as parameters (7) and (8), respectively. The only remaining parameters that are required to characterize our model are the progressor fractions { }. We allow 0 to be one of our required model parameters and assume that each progressor fraction with ≥ 1 is uniquely determined by the mean and standard deviation of a "discrete normal distribution", denoted and , respectively. This is consistent with the "division destiny" approach for determining progressor fractions that was employed in [14] and [4] , and we refer the interested reader to [4] for a complete discussion of the method by which the progressor fractions are computed. We therefore have three parameters that can be used to determine all the progressor fractions: 0 , , and , which are listed as parameters (10) through (12), respectively. Consequently, our speci c model depends on exactly twelve parameters. We remark that parameters (1) through (3), while important for describing the data, are not considered to be "biologically relevant" parameters in the sense that they do not have any bearing on the proliferative behavior of a population of cells. Also, parameters (4), (6) , (8) , and (10) are perhaps the most important of the biologically relevant parameters because their interpretation in the context of cell proliferation is the most straightforward. Note that the speci c cyton-based model described here is denoted Model 6 (with exponential label decay) in [4] . Precise details of our methods for computing numerical solutions for this model are provided in the appendix of [4] .
Parameter estimation
In order to estimate the parameters in our speci c mathematical model, we must rst describe a statistical model that relates observable data to the mathematical model. As was previously explained, CFSE ow cytometry data are typically summarized in the form of histograms, and furthermore, measured FI is commonly represented on a logarithmic scale (cf. Figures 1 through 8) . Therefore, we begin by describing how our model can be used to obtain information on cell numbers in a form that can be compared directly with such summarized experimental data.
If we de ne the structured densities̃ ( ,̃ ) (in terms of measured FI) as in Section 3, then the structured density for the entire population of cells is
(See Section 3.1 for a discussion of how to choose max appropriately.) Now, because CFSE histogram data are most commonly reported using a base 10 logarithmic scale, we let = log 10 (̃ ) so that ( , ) = 10 log(10)̃ ( , 10 )
gives the structured density in cells per base 10 log unit FI.
In the discussion that follows, we let ⃗ 0 denote a hypothetical "true" parameter vector (so that, in the case of our speci c mathematical model, ⃗ 0 ∈ ℝ 12 ) and let
denote the total number of cells with log (base 10) FI in the interval [ , +1 ] at time . Also, we let denote the ( xed) total number of beads in each sample tube and denote the number of beads counted for the sample measured at time . Now, let be a random variable representing the number of cells with log FI in the interval [ , +1 ) measured at time . Then it has been argued [4] that
i.e., each is normally distributed with mean [̂ ]( , ; ⃗ 0 ) and variance ( / ) [̂ ]( , ; ⃗ 0 ). Note that this does not lead to either (1) a constant variance model or (2) a constant coe cient of variance model. Though these latter two types of statistical models are commonly assumed to underly data-collection processes [9, 11, 20] , modi ed residual plots indicate that (4.2) is a better choice in this case [5, 22] .
De ne the generalized least squares (GLS) parameter estimator [2, 11] 
where
denotes the space of allowable parameter vectors, and the weights (selected to match the variance of the random variables ) are given by
The value of * is positive to prevent division by zero, and in practice it is selected such that the modi ed residual plots produce uniform random patterns. We once again follow the convention of [4] and set * = 200.
If we consider the measured data to be a set of realizations { } of the random variables { }, we can obtain the GLS parameter estimatê
Note that to compute the weights { } we need ⃗ 0 , but to estimate ⃗ 0 we need the weights. In order to overcome this obstacle, we use a conventional generalized least squares iterative estimation procedure [2, 9] as described in Algorithm 4.1. In this algorithm, note that is a threshold tolerance that allows the user to specify a termination criterion, ⃗ typ is a vector with elements that re ect the relative sizes of the parameters to be estimated, and "./" denotes element-wise division. • Computê (ℓ) using (4.4) with current weights .
• Update the weights using (4.3) with ⃗ 0 replaced bŷ (ℓ) .
• Store the value of
Step 4. Otherwise, terminate the algorithm.
For our purposes, we used the MATLAB routine fmincon (with the active-set optimization algorithm speci ed) to solve the minimization problems in Steps 1 and 4 of Algorithm 4.1. Also, we set ⃗ typ = (100, 100, 0.001, 1, 1, 1, 1, 1, 1, 0.1, 1, 1) and chose = 0.05 for our implementation.
Results and discussion
In this section, we discuss the results of our study. Since triplicate measurements were collected at each point in a ve-day time series, we are able to analyze the variability that exists in the data itself. Also, since these triplicate measurements make it possible to construct a large number of ve-day data sets, we are able to analyze variability in the corresponding sets of parameter estimates. We consider experimental variability in the estimates for individual parameters (for each speci c combination of donor, ViViD dye status, and cell type) as well as biological variability (i.e., di erences between the parameter estimates obtained for di erent donors and di erent cell types).
. Variability in the data
It is clear from Figures 1 through 8 that, while the shapes of the histograms summarizing observed data do not vary much between triplicate experiments for any particular day and combination of donor, ViViD dye status, and cell type, the scale of the histograms can vary considerably. That is, there can be a signi cant di erence between triplicate experiments in the number of cells represented in the respective histograms. One can also see in Figures 1 through 8 that there seems to be more variability in the cell counts at the later time points (those corresponding to Day 4 and especially those corresponding to Day 5) . Tables 2 through 6 list the cell counts for each sample and each combination of donor, ViViD dye status, and cell type on Days 1 through 5, respectively, and can be compared with the histograms in Figures 1 through 8 . For example, Table 2 shows all the cell counts in the various samples represented in the upper-left (Day 1) plots for each of Figures 1  through 8 . Tables 2 through 6 also show an estimate of the coe cient of variation based on each row of sample cell counts. The coe cient of variation is a measure of the relative variation in the cell counts, and can be estimated aŝ
wherē denotes the sample mean of the cell counts (in the relevant biological samples) and denotes the sample standard deviation. We refer tô as an "estimate" because it is derived from a nite "sample" of data (in our case, from three cell counts derived from three biological samples). The true coe cient of variation would be computed as
where and are the mean and standard deviation, respectively, of cell counts for the "population" of all possible biological samples for the speci c time, donor, ViViD status, and cell type in question. Table 3 . Status of cell cultures at Day 2. The numbers in the columns corresponding to Samples 1, 2, and 3 represent cell counts after scaling (using bead counts). Each number in the C.V. column represents the coe cient of variation for the cell counts in the corresponding row.
In order to understand how variation in the cell counts arises, recall from Section 2 that approximately one million cells were placed into each of several wells, and that each distinct sample was drawn from a distinct well. Because of the experimental error inherent in seeding the wells, we expect that each well actually started out with a di erent number of cells. We should remark here that the numbers in Tables 2  through 6 do not represent total cell counts, but rather they represent cell counts for speci c types of Table 6 . Status of cell cultures at Day 5. The numbers in the columns corresponding to Samples 1, 2, and 3 represent cell counts after scaling (using bead counts). Each number in the C.V. column represents the coe cient of variation for the cell counts in the corresponding row.
cells (CD4+ or CD8+ T cells) under speci c conditions (donor and ViViD dye status). So, for example, if we attempt to seed one million cells from Donor 1 into a well and the true proportion of CD4+ T cells is 15% for this donor, there should be about 150 thousand CD4+ T cells in the well at time = 0; however, there will be some variation in this number (150 thousand) because of the variation in the total cell population number (one million). We did not make any measurements at time = 0, so we cannot directly assess the variation present in the numbers of cells initially seeded into the wells. Our best approximation of this initial variation comes from the cell counts observed on Day 1, which are shown in Table 2 . Also, because the true proportion of cells (out of approximately one million) corresponding to a particular day, donor, ViViD dye status, and cell type varies, we cannot directly compare all 24 cell count numbers in one of the tables, and we cannot directly compare the eight sample variances or sample standard deviations obtained for the eight rows in any given table. To be clear, we cannot use such direct comparisons because the magnitudes of the cell count numbers tend to be di erent in each row of a given table. We can, however, compare some measure of relative variation for each of the rows of a given table. The coe cient of variation described previously is one such measure. So, the eight numbers listed in the last column of Table 2 give some indication of the variability we expect when attempting to seed one million cells into a well, and, importantly, they can be compared with one another. If we assume that the seeding of one million cells into a well is a process that is subject to random error, then the amount of error is a random variable with some well-de ned probability distribution. For our purposes, the "amount of error in the initial seeding" is synonymous with the "amount of relative variation in the cell counts at Day 1", which we choose to measure using the coe cients of variation described previously. One important question to consider, then, is whether or not the amount of relative variation in cell counts (or more precisely, the sampling distribution of this statistic) changes between measurement times (days). As was previously asserted, Figures 1 through 8 provide convincing evidence that the amount of relative variation in cell counts does change with respect to time. More speci cally, these gures lead us to suspect that there is a signi cant di erence between the relative variation observed in the earlier days of the experiment (1 through 3) and that observed in the later days (4 and 5). The coe cient of variation estimates in the last columns of Tables 2 through 6 can be used to demonstrate this claim conclusively through the use of formal statistical hypothesis testing.
The two-sided Wilcoxon rank-sum test allows one to determine if two independent samples have been drawn from the same continuous distribution [15] . In our case, we assume that the eight coe cient of variation numbers corresponding to Day are a random sample of a continuous random variable with cumulative density function (cdf) for ∈ {1, 2, 3, 4, 5} and that each of the ve samples is independent of all of the others. Thus, for any particular pair of days ( , ), we would like to test the null hypothesis that the corresponding samples of coe cient of variation numbers were drawn from the same population of values (or, equivalently, from two populations with identical cdfs); i.e., 0 :
( ) = ( ) for all .
For the Wilcoxon test, the alternative hypothesis is that one of the two samples was drawn from a population that tends to have larger values than the population from which the other sample was drawn (or, equivalently, that one of the two corresponding distributions is stochastically larger than the other); i.e., : ( ) ≤ ( ) for all , with strict inequality for at least some , or ( ) ≥ ( ) for all , with strict inequality for at least some .
As with any statistical hypothesis test, the Wilcoxon test produces a "test statistic" that can be converted into a " -value". The -value indicates the probability of obtaining a test statistic at least as extreme as the one which was actually observed assuming that the null hypothesis is true. If we use a "signi cance level" of 0.05, then we are asserting that outcomes with probability less than 0.05 are unlikely to occur. Therefore, we should reject the null hypothesis whenever the -value is less than 0.05.
Suppose, for example, that we want to test the claim that there is no di erence between the distribution of relative variations in cell counts observed at Day 1 and that observed at Day 2. This null hypothesis can be formalized as 0 :
1 ( ) = 2 ( ) for all , where 1 and 2 denote the cdfs for the coe cients of variation in cell counts at Days 1 and 2, respectively. The alternative hypothesis is that one of the two distributions is stochastically larger than the other; i.e.,
:
1 ( ) ≤ 2 ( ) for all , with strict inequality for at least some , or 1 ( ) ≥ 2 ( ) for all , with strict inequality for at least some .
We can use the coe cient of variation estimates from Tables 2 and 3 to perform a Wilcoxon test for these hypotheses. That is, we can compare the eight coe cient of variation numbers from Table 2 with the eight coe cient of variation numbers from Table 3 using a Wilcoxon test. Based on the -value of 0.2345 that results from performing this test, we fail to reject the null hypothesis (using a 0.05 signi cance level) and conclude that there is not a statistically signi cant di erence between the relative variations in cell counts observed at Days 1 and 2, respectively. Similarly, we can perform Wilcoxon tests to conclude that there is not a statistically signi cant di erence between the relative variations in cell counts observed at Days 1 and 3 ( = 0.8785) or the relative variations in cell counts observed at Days 2 and 3 ( = 0.1304). On the other hand, Wilcoxon tests lead us to conclude that there is a statistically signi cant di erence between the relative variations in cell counts observed at Days 1 and 4 ( = 0.03792) and between the relative variations in cell counts observed at Days 1 and 5 ( = 0.02813). Similarly, there appears to be a statistically signi cant di erence between the relative variations in cell counts observed at Days 2 and 5 ( = 0.03792) and between the relative variations in cell counts observed at Days 3 and 5 ( = 0.01476). (Wilcoxon tests do not indicate a signi cant di erence between relative variations in cell counts observed at Days 2 and 4 or Days 3 and 4, but recall that at least some of the Day 4 coe cients of variation are based on fewer cell counts because fewer biological samples were used for Donor 1 on Day 4; therefore, information concerning variation in cell counts for Day 4 is considerably less reliable.)
We propose that this change in the relative variation of the cell counts with respect to time cannot be explained by proliferation dynamics. In fact, if we assume that our mathematical model describing cell proliferation is correct, the relative variation in cell counts for distinct cultures proliferating with the same dynamics should not change in time. Relative variation can be measured in terms of percent di erences or coe cients of variation and we o er proofs of the assertion in the preceding sentence with respect to both of these measures of relative variation in [3, Appendix A], but it is easy (and instructive) to understand the validity of the assertion under the assumption of a simple exponential growth model. So, consider two cultures of cells, " " and " ", that are proliferating at the same exponential growth rate . If 0 and 0 denote the initial numbers of cells present in cultures and , respectively, then 
Therefore, the percent di erence in cell counts does not change with respect to time. Note that the amount of statistical variation (e.g., di erence) in the cell counts does generally change in time, but the relative variation (e.g., percent di erence) must remain constant. Since we have clearly demonstrated that the relative variation in the cell counts does, indeed, change between Days 1, 2, and 3 and Day 5, some source of variability must exist which is not accounted for in our model. We propose that the exchange of nutrient medium starting at Day 3 could be such a source of variability. Exchange of nutrient medium could feasibly remove, disturb, or damage some of the cells in the a ected wells, and it would certainly change the amount of nutrient available to the cells in those wells. In fact, the very reason that the nutrient medium is replenished starting at Day 3 is that by that time it has begun to change color, indicating that the nutrient levels have declined. So, in addition to the changes in the amount of nutrient available to the cell cultures that occur at discrete points in time corresponding to nutrient medium exchange, we may infer that cells growing and dividing in the various cell cultures signi cantly deplete nutrients in their respective wells throughout the experiment.
. Variability in the parameter estimates
In order to assess variability in parameter estimates, we applied the parameter estimation technique described in Section 4 to the various ve-day time series data sets described in Section 2. For each of the twelve parameters from our speci c mathematical model and each of the eight combinations of donor ("Donor1" or "Donor2"), ViViD dye status ("Vivid" indicating that ViViD dye was used to exclude dead cells or "NoVivid" indicating otherwise), and cell type ("CD4" or "CD8"), this led to either 162 or 243 (depending on donor, cf. Section 2) parameter estimates. Each such set of parameter estimates can be represented by a box plot, so for each model parameter we can construct eight box plots. To illustrate this we provide Figure 9 , which shows the parameter estimation results for the model parameters and E[ die ] for each combination of donor, ViViD dye status, and cell type. The box plots in this gure adhere to the following conventions: (i) the median value is indicated by a red line; (ii) the rst and third quartiles ( 1 and 3 ) are indicated by the lower and upper boundaries of the blue box, respectively; (iii) any value that falls above 3 + 1.5( 3 − 1 ) or below 1 − 1.5( 3 − 1 ) is considered to be an outlier, and is indicated by a "+"; and (iv) the black horizontal lines above and below the box (which are in most cases connected to the box via dashed vertical lines) represent the maximum and minimum values, respectively, excluding outliers. Sets of box plots such as those described above can provide a wealth of information concerning the variability in parameter estimates and identi ability of the corresponding parameters. Individually, each box plot can be used to determine a median parameter estimate and to visualize the variation (spread) in parameter estimates for a given donor and cell type when multiple ve-day data sets are considered. The amount of spread in each box plot can also be used to conclude whether or not a particular parameter is likely to be identi able for any particular donor and cell type. For example, Figure 9 reveals extremely large spreads in many of the box plots corresponding to the parameter E[ die ], indicating that this model parameter may not be identi able. On the other hand, all of the box plots corresponding to the parameter have relatively small spreads, indicating that this model parameter can be estimated with relatively high reliability. Taken together, all the box plots corresponding to a given parameter allow for useful comparisons of the parameter estimates that are obtained for di erent combinations of donor, vivid dye status, and cell type. For example, if we consider the box plots in Figure 9 corresponding to the parameter , we can make a number of interesting conclusions. First, the use of ViViD dye does not appear to lead to a statistically signi cant di erence in the estimate obtained for the parameter (cf. box plots 1 and 3, 2 and 4, 5 and 7, and 6 and 8, numbering sequentially from left to right). Next, the estimate for is larger for CD8+ T cells than for CD4+ T cells when considering data for Donor 1 (cf. box plots 1 and 2 or 3 and 4), but it is larger for CD4+ T cells than for CD8+ T cells when considering data for Donor 2 (cf. box plots 5 and 6 or 7 and 8). Finally, while there does not appear to be a statistically signi cant di erence between Donor 1 and Donor 2 in the estimate obtained for when considering CD4+ T cells (cf. box plots 1 and 5 or 3 and 7), the Donor 1 estimate is considerably larger than the Donor 2 estimate when considering CD8+ T cells (cf. box plots 2 and 6 or 4 and 8).
. . Remarks on basic parameter estimates
We next summarize all the conclusions that can be drawn by analyzing box plots corresponding to parameter estimates for all twelve of our model parameters. In Figure 9 , we only show box plots for the parameters and E[ die ], but the interested reader can nd box plots for all twelve parameters in [3, Figures 9 through 20 ].
One general conclusion that can be made from these gures is that the use of ViViD dye does not seem to have a large e ect on the estimates obtained for most of the model parameters. Therefore, in the discussion that follows we will focus on the box plots summarizing "NoVivid" data sets. Box plots summarizing estimates for the parameter E[ ], which represents the mean auto uorescence, are shown in [3, Figure 9 ]. The 3rd and 4th box plots in that gure indicate that there is a considerable di erence in the mean auto uorescence of CD4+ T cells and CD8+ T cells obtained from Donor 1. (Note that the box plots do not "overlap".) More speci cally, CD8+ T cells appear to have a larger mean auto uorescence than CD4+ T cells for Donor 1. On the other hand, the 7th and 8th box plots indicate that CD4+ T cells have a larger mean auto uorescence than CD8+ T cells when considering cells obtained from Donor 2. When we compare CD4+ T cells obtained from the two distinct donors (compare 3rd and 7th box plots), it appears that E[ ] is larger for Donor 2 than for Donor 1. When comparing CD8+ T cells from the two donors (compare 4th and 8th box plots), it appears that E[ ] is larger for Donor 1 than for Donor 2. In [3, Figure 10 ], we provide box plots summarizing estimates for standard deviation of the autouorescence, SD[ ]. As with the mean auto uorescence, it appears that the value of this parameter is larger for CD8+ T cells than for CD4+ T cells in the case of Donor 1 and larger for CD4+ T cells than for CD8+ T cells in the case of Donor 2. Also, when comparing CD4+ T cells obtained from the two distinct donors, it appears that SD[ ] is larger for Donor 2 than for Donor 1, and when comparing CD8+ T cells from the two donors, it appears that SD[ ] is larger for Donor 1 than for Donor 2.
Box plots summarizing estimates for the parameter , which describes exponential decay of CFSE, are shown in [3, Figure 11 ]. It appears that the value of this parameter is larger for CD8+ T cells than for CD4+ T cells in the case of Donor 1 and larger for CD4+ T cells than for CD8+ T cells in the case of Donor 2. When we compare CD4+ T cells obtained from the two distinct donors, there does not appear to be a signi cant di erence in the parameter ; however, when comparing CD8+ T cells from the two donors, it appears that is larger for Donor 1 than for Donor 2.
In [3, Figure 12 ], we provide box plots summarizing estimates for the parameter E[ Box plots summarizing estimates for the parameter 0 , which represents the progressor fraction for undivided cells, are shown in [3, Figure 18 ]. It appears that the value of this parameter is larger for CD8+ T cells than for CD4+ T cells in the case of Donor 1 and larger for CD4+ T cells than for CD8+ T cells in the case of Donor 2. When we compare CD4+ T cells obtained from the two distinct donors, there does not appear to be a signi cant di erence in the parameter 0 ; however, when comparing CD8+ T cells from the two donors, it appears that 0 is larger for Donor 1 than for Donor 2.
In [3, Figure 19 ], we provide box plots summarizing estimates for the parameter . There does not appear to be a signi cant di erence in the value of this parameter for CD4+ and CD8+ T cells in the case of Donor 1, but the parameter value is larger for CD8+ T cells in the case of Donor 2. When we compare CD4+ T cells obtained from the two distinct donors, there does not appear to be a signi cant di erence in the parameter ; however, when comparing CD8+ T cells from the two donors, it appears that is larger for Donor 2 than for Donor 1.
Box plots summarizing estimates for the parameter are shown in [3, Figure 20 ]. It appears that the parameter value is larger for CD8+ T cells than CD4+ T cells in the case of Donor 1, but there does not appear to be a signi cant di erence in the parameter value for CD4+ and CD8+ T cells in the case of Donor 2. When we compare CD4+ T cells obtained from the two distinct donors, it appears that is larger for Donor 2 than for Donor 1. On the other hand, when comparing CD8+ T cells from the two donors, there does not appear to be a signi cant di erence in the parameter .
We have already noted that many of our model parameters can be estimated with relatively high reliability, while others do not appear to be identi able, but thus far all of our arguments have been based upon visual inspection of the box plots in [3, Figures 9 through 20] . To allow for more careful quantitative analysis of the identi ability of parameters, we provide in Tables 7 through 18 some of the summary statistics used to generate the box plots in those gures. For example, in Table 7 we provide a median and an interquartile range (IQR) corresponding to each of the box plots [3, Figure 9 ]. Since the median and IQR indicate the "center" and "spread", respectively, for a set of parameter estimates, the ratio of these two quantities provides a useful measure of "relative spread". We therefore also include a column for the ratio of IQR to median in each of Tables 7 through 18 . When the spread is greater than 50% of the central value for a particular set of parameter estimates (i.e., whenever the ratio of IQR to median is greater than 0.50), we consider the variability in that set of parameter estimates to be "relatively high" and conclude that the parameter may not be identi able; therefore, the ratios meeting this criteria are emphasized in boldface in the tables. Note that the value 0.50 was chosen somewhat arbitrarily, but comparing Tables 7 through 18 with [3, Figures 9 through 20 ] makes it clear that such a value for the ratio of IQR to median does, indeed, indicate a "large" relative spread in a set of parameter estimates.
Based on Tables 7 through 18 , we conclude that the model parameters
, and can all be estimated with fairly high reliability. On the other hand, the parame-
, and SD[ die ] each have very high ratios of IQR to median in some cases, indicating that they may not be identi able. We conjecture that this could be because the mathematical model is not sensitive to these particular parameters. One might reason, for example, that the lack of model sensitivity to the parameters involving "time until death" occurs because divided cells (those cells for which ≥ 1) tend to divide much more often than they die (when considering stimulated T cells from healthy donors) and such behavior can be correctly incorporated into the model as long as the expected time until division,
is signi cantly smaller than the expected time until death, E[ die ]. To be more speci c (and to reuse some terminology that was utilized in Section 5.1), as long as the distribution of the random variable die tends to be stochastically larger (by a substantial margin) than that of div , the correct dynamical behavior of the system can probably be modeled adequately (at least over the rst few days) even if the parameters describing the distribution of die are not estimated very accurately. To illustrate this point, consider Figures 10 and 11 , in which we plot the (lognormal) distributions of the random variables div and die in two di erent cases.
In both cases we use the same set of parameter values for div , but in each case a di erent set of a parameter values is used for die . The values of die tend to be larger than those of div in both cases, so in both situations cells should tend to divide more frequently than they die. (Recall that the fate of any particular cell is determined by whichever of these two random variables produces a smaller realization.) We argue that, when all other parameters are xed using some common set of values, the model output does not vary signi cantly (at least over the rst few days) when the two di erent sets of parameter values for die indicated in Figures 10 and 11 are used. To demonstrate this claim, we show sample model output generated using these two di erent sets of parameter values for die in Figure 12 . The complete sets of parameter values for "Model A" and "Model B" are provided in Figure 20 ]). We chose to x the values of the two selected parameters at the (approximate) median estimates obtained from the basic parameter estimation scheme (with no xed parameters). Since these medians vary for the di erent combinations of donor, ViViD dye status, and cell type, we used di erent xed values for each of these combinations. The speci c xed values used for E[ respectively. Our goal in xing the value of one or more parameters is to reduce the variability in the parameter estimates for other parameters, so we need to select some measure of variability for the analysis. Throughout the discussions that follow, we will use the interquartile range (IQR) as a rough measure of variability in the parameter estimates for a given combination of donor, ViViD dye status, and cell type. Table 19 . Parameter values used to obtain summary histogram output for Models A and B in Figure 12 . Values which di er in the two models are emphasized in boldface. 
. . Parameter estimates obtained using only data for Days 1 through 3
As was demonstrated in Section 5.1, the amount of relative variation in the cell counts undergoes signi cant changes between Day 3 and Day 5. We therefore also attempted to estimate parameters using only data from Days 1 through 3. Figures 9 through 20 ] reveals that there are clear di erences between the parameter estimates obtained using three-day data sets and those obtained using complete data sets. For a complete discussion of the di erences, see [3, Section 5.2.5] . This outcome further supports the evidence given in Section 5.1 that the periodic exchange of nutrient medium starting at Day 3 causes changes to the counts and/or the proliferative behavior (as described by our cyton-based dynamical models) of the a ected cell cultures.
Conclusion
In this document, we have presented the ndings of our recent investigation into the variability that exists in CFSE-based ow cytometry data in the context of cyton-based mathematical models for cell proliferation. We have described the speci c mathematical model that we consider, as well as a generalized least squares scheme that allows one to estimate the parameters in that mathematical model using CFSE ow cytometry data. By applying our parameter estimation scheme to a large body of data, we were able to assess both experimental and biological variability in the resulting parameter estimates. In this section of the document, we will summarize our ndings and utilize them to make some important conclusions concerning both standard CFSE ow cytometry experimental procedures and the current generation of mathematical models that are used to analyze data that result from these procedures.
We begin by summarizing our results concerning identi ability of the various parameters in our model. As was discussed in Section 5. do not appear to be identi able. As a possible explanation of this, we proposed that the model may not be sensitive to the parameters involving die at the earlier time points (i.e., Days 1 through 3). We also provided an example (cf. Figures 10 through 12) which indicated that the model may be more sensitive to these parameters at the later time points (i.e., by Day 5). Unfortunately, another key nding of this study is that the accuracy of in vitro CFSE ow cytometry data appears to decrease signi cantly after Day 3. We hypothesize that cell culturing protocols (and speci cally the depletion and replenishment of nutrient medium) lead to increase of variability in measured triplicate data after Day 3. A number of di erences between the parameter estimates observed for distinct donors and cell types are outlined in Section 5.2.1, but it is di cult to state the relationships described there in a more concise way. We would like to revisit, however, one interesting general result that arose in Section 5.2.1: the use of ViViD dye does not seem to have a signi cant e ect on the estimates obtained for most of the model parameters. Interestingly, the largest fractions of dead cells are typically identi ed (using ViViD) in the rst three days of the experiment (cf. Tables 2 through 6); i.e., the largest relative errors in cell counts due to the counting of dead cells (when not using ViViD to omit them) occurs in the earliest days of the experiment. This may be because the large die-o of cells that occurs immediately following PHA stimulation (which was mentioned in Section 3.5) leaves a considerable number of dead (but not yet disintegrated) cells in its wake at the beginning of the experiment. Presumably these cells are able to disintegrate completely by Day 4, at which point the fractions of dead cells identi ed using ViViD are much smaller. Whatever the reason, it seems that errors in cell counts caused by the inclusion of dead cells are likely to be largest when errors in the true cell counts, themselves, are smallest (cf. Section 5.1). Also, errors in cell counts caused by the inclusion of these cells are likely to be smallest when errors in the true cell counts, themselves, are largest. So, although the use of ViViD dye may not appear to be bene cial in the estimation of parameters based on the results of this study, use of ViViD may prove to be bene cial in later studies if new techniques make it possible to obtain more precise true cell counts.
We implemented several variations to our basic parameter estimation scheme in an attempt to reduce variability in parameter estimates. In Section 5. In fact, there may be some interplay between these parameters and other model parameters similar to the hypothetical interplay between time-to-division and time-to-death parameters discussed at the end of Section 5.2.1. Furthermore, even if the parameters in question are not in uential, xing them will not necessarily result in improved estimates for other parameters. (The data itself may contain little or no information on these speci c parameters.) Thus, the discovery that xing one or both of the parameters in question was not advantageous should not be particularly surprising or counterintuitive. We also implemented a variation of our basic parameter estimation scheme in which only data from Days 1 through 3 were utilized. As was outlined in Section 5.2.3, clear di erences exist between the parameter estimates obtained using three-day data sets and those obtained using complete data sets. This outcome, along with the evidence presented in Section 5.1, seems to indicate that the periodic exchange of nutrient medium starting at Day 3 does a ect the proliferation of cells in the cell culture wells that are processed after Day 3. Furthermore, the very fact that the exchange of nutrient medium is necessary allows one to infer that cell cultures deplete nutrients in their respective wells throughout the experiment. Such changes in the cell culture environments unfortunately contradict the underlying assumptions of our model. In particular, the cyton model that we have incorporated into our mass-and energy-conserving mathematical model tacitly assumes a constant environment for cultures of proliferating cells. (Note that the time-dependence of the cytons {( ( ), ( ))} is actually based on "time since the last division occurred", or time in the frame of reference of an individual cell. The cytons therefore have no dependence on "real time", or time in the frame of reference of the experimenter. In real time, the conditions in the nutrient medium are apparently changing, and the basic cyton model is not capable of handling such a non-constant environment.) Thus, several observations made in this report indicate that the standard cell culturing protocol used for CFSE ow cytometry experiments does not provide a constant environment for cells growing in the wells. Adjustments could be made to the model, of course, to allow for time-dependence of the cytons, but any such adjustments would most likely lead to overparameterization; i.e., the increase in the number of parameters required by such adjustments would probably lead to even further identi ability issues. Furthermore, environmental changes caused by the exchange of the nutrient medium at discrete time points would probably be very di cult to quantify. It is worth noting that, in cases where a smaller total number of cells is stimulated (e.g., in response to antigen-speci c challenges) the depletion of nutrient medium may not be signi cant over the course of a ve-day experiment; thus, the exchange of nutrient medium may be unnecessary in such cases.
As a nal point, we would like to re-emphasize that typical CFSE ow cytometry data are not truly longitudinal (cf. Section 2). For this reason, it appears that our ability to validate (and estimate parameters for) the latest generation of division-and label-structured cell population models (presented here) is limited by the precision with which experimenters can seed a set of cell culture wells. (Recall that, upon seeding, we assume all wells to be identical in that they include the same numbers of total cells in the same proportions.) The results presented in this report suggest that the use of time series data which are not truly longitudinal (which is the current standard protocol for in vitro CFSE ow cytometry experiments) leads to high variability in estimates for many of the relevant parameters in our model. This could be because the numbers of cells used to seed two distinct wells, which are assumed to be identical and which will be harvested and analyzed to produce data for two distinct points in the time series, can di er by 16% or more (cf. Table 2 ). (We should mention here the possibility that experimenters may actually seed the wells with much higher precision than seems to be the case, and that poor precision in bead counts might be the true cause of the apparent discrepancies in total cell numbers. This possibility was considered in [4] , and a statistical model was formulated there to account for errors in bead counts, but we believe such a model adjustment leads to overparameterization.) This issue of poor precision in total cell counts, along with the issue of non-constant environment, suggests that substantive changes to CFSE ow cytometry and in vitro cell culturing protocol and/or signi cant modi cations to our mathematical model need to be considered.
We reiterate that, for this study, we have only considered PHA-stimulated cells. Because it is a non-speci c T cell mitogen, PHA stimulates all T cells to begin dividing and therefore leads to a somewhat arti cial situation from an immunological perspective. Nevertheless, the methods and results presented in this report indicate that many of the important and biologically relevant parameters for describing T cell proliferation can be reliably estimated using our approach. As more realistic and interesting experiments are devised and carried out (e.g., Gag protein stimulation of cells from HIV-positive donors), it is our hope that the challenges and concerns presented here will be utilized to develop and select models that account for variability in experimental data.
